Literature DB >> 2547364

Extracellular appearance of calpain and calpastatin in the synovial fluid of the knee joint.

I Fukui1, K Tanaka, T Murachi.   

Abstract

Extracellular location of calpain and calpastatin was demonstrated in the cell-free synovial fluid obtained from the knee joint of healthy adult humans and several patients with rheumatoid arthritis. Calpains I and II and a few molecular species of calpastatin were identified by chromatographies on DEAE-cellulose and on Ultrogel AcA 34 columns as well as by immunoelectrophoretic blot analysis. Calpains I and II in the synovial fluid of the patients increased 6.7 times and 3.5 times, respectively, compared with those of the control subjects. With the patients, shortening of the heavy subunits of calpains was noted. Calpastatin also increased in the patients, but it showed rather extensive fragmentation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547364     DOI: 10.1016/0006-291x(89)92347-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha.

Authors:  Y Kobayashi; K Yamamoto; T Saido; H Kawasaki; J J Oppenheim; K Matsushima
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Autoantibodies directed against the protease inhibitor calpastatin in psoriasis.

Authors:  Y Matsushita; Y Shimada; S Kawara; K Takehara; S Sato
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

3.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

4.  Appearance of calpain correlates with arthritis and cartilage destruction in collagen induced arthritic knee joints of mice.

Authors:  Z Szomor; K Shimizu; Y Fujimori; S Yamamoto; T Yamamuro
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases.

Authors:  T Mimori; K Suganuma; Y Tanami; T Nojima; M Matsumura; T Fujii; T Yoshizawa; K Suzuki; M Akizuki
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

6.  Intracellular versus extracellular inhibition of calpain I causes differential effects on pain in a rat model of joint inflammation.

Authors:  Jason J McDougall; Miranda McConnell; Allison R Reid
Journal:  Mol Pain       Date:  2021 Jan-Dec       Impact factor: 3.395

7.  Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-κB and increased STAT5 signals.

Authors:  Mikiko Iguchi-Hashimoto; Takashi Usui; Hajime Yoshifuji; Masakazu Shimizu; Shio Kobayashi; Yoshinaga Ito; Kosaku Murakami; Aoi Shiomi; Naoichiro Yukawa; Daisuke Kawabata; Takaki Nojima; Koichiro Ohmura; Takao Fujii; Tsuneyo Mimori
Journal:  PLoS One       Date:  2011-10-27       Impact factor: 3.240

8.  Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage.

Authors:  Ian C Scott; Jayesh B Majithiya; Caroline Sanden; Peter Thornton; Philip N Sanders; Tom Moore; Molly Guscott; Dominic J Corkill; Jonas S Erjefält; E Suzanne Cohen
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

Review 9.  Proteases involved in cartilage matrix degradation in osteoarthritis.

Authors:  Linda Troeberg; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2011-07-08

10.  Calpastatin-Mediated Inhibition of Calpain Ameliorates Skin Scar Formation after Burn Injury.

Authors:  Cheong Hoon Seo; Hui Song Cui; June-Bum Kim
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.